FDA
label_change
· 2021-04-28
FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
Summary
FDA approved a supplemental application for Ketorolac tromethamine from Hikma Pharmaceuticals USA Inc., updating the labeling of the product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)